Palivizumab Treatment of Respiratory Syncytial Virus Infection after Allogeneic Hematopoietic Stem Cell Transplantation

Among 40 allogeneic stem cell transplant recipients who developed symptomatic respiratory syncytial virus infection, including 22 patients with lower respiratory tract infection, 19 received palivizumab (9 of whom had upper respiratory tract disease). Palivizumab did not prevent progression to lower...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2007-10, Vol.45 (8), p.1019-1024
Hauptverfasser:	de Fontbrune, Flore Sicre, Robin, Marie, Porcher, Raphael, Scieux, Catherine, de Latour, Régis Peffault, Ferry, Christèle, Rocha, Vanderson, Boudjedir, Karim, Devergie, Agnès, Bergeron, Anne, Gluckman, Eliane, Azoulay, Elie, Lapalu, Jordane, Socié, Gérard, Ribaud, Patricia
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Antiviral Agents - therapeutic use Biological and medical sciences Blood donation Bone marrow Bone marrow, stem cells transplantation. Graft versus host reaction Brief Reports Child Child, Preschool Cord blood Hematologic Diseases - complications Hematopoietic Stem Cell Transplantation Human respiratory syncytial virus Human viral diseases Humans Immunomodulators Infections Infectious diseases Medical sciences Middle Aged Monoclonal antibodies Mortality Palivizumab Pharmacology. Drug treatments Pneumonia - drug therapy Pneumonia - virology Respiratory diseases Respiratory syncytial virus Respiratory syncytial virus infections Respiratory Syncytial Virus Infections - drug therapy Respiratory syncytial viruses Respiratory tract infections Respiratory Tract Infections - drug therapy Respiratory Tract Infections - virology Retrospective Studies Stem cells Survival Analysis Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplants & implants Viral diseases Viral diseases of the respiratory system and ent viral diseases Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Among 40 allogeneic stem cell transplant recipients who developed symptomatic respiratory syncytial virus infection, including 22 patients with lower respiratory tract infection, 19 received palivizumab (9 of whom had upper respiratory tract disease). Palivizumab did not prevent progression to lower respiratory infection and had no impact on the overall survival rate.
ISSN:	1058-4838 1537-6591
DOI:	10.1086/521912